India  

AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

AstraZeneca: British-Swedish pharmaceutical company
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford-AstraZeneca COVID-19 vaccine.

1
shares
ShareTweetSavePostSend
 
EU reaches vaccine delivery deal with AstraZeneca, ending legal battle over supply delays [Video]

EU reaches vaccine delivery deal with AstraZeneca, ending legal battle over supply delays

The Commission and the company have struck a deal to guarantee all the 300 million doses will be delivered by the end of March 2022.

Credit: euronews (in English)     Duration: 01:08Published

COVID vaccine: AstraZeneca is more effective than Pfizer, study reveals (1) [Video]

COVID vaccine: AstraZeneca is more effective than Pfizer, study reveals (1)

COVID vaccine: AstraZeneca is more effective than Pfizer, study reveals (1)

Credit: Wochit News     Duration: 01:05Published

You Might Like


AstraZeneca to roll out in India multiple Covid therapies in 2022


IndiaTimes - Published

PM tells unjabbed Brazil leader to 'get the vaccine' in awkward exchange

pm tells unjabbed brazil leader to 'get the vaccine' in awkward exchange
Boris Johnson told Brazilian president Jair Bolsonaro to "get the AstraZeneca vaccine" in an awkward exchange with the unvaccinated South American leader.
Sky News - Published

Booster jabs 'set for go-ahead next week' - but vaccine creator says not everyone may need them

booster jabs 'set for go-ahead next week' - but vaccine creator says not everyone may need them
Booster vaccines are reportedly set to be given the go-ahead next week, despite a professor who helped develop the AstraZeneca jab warning that a mass campaign may not be necessary.
Sky News - Published

AstraZeneca and Pfizer safe to use as booster jabs, UK medicines regulator says

astrazeneca and pfizer safe to use as booster jabs, uk medicines regulator says
The UK's medicines regulator has said the Pfizer-BioNTech and Oxford-AstraZeneca coronavirus vaccines are safe to use as booster jabs.
Sky News - Published

Booster jabs may not be needed for everyone and widespread rollout could put pressure on NHS, says AZ boss

booster jabs may not be needed for everyone and widespread rollout could put pressure on nhs, says az boss
The boss of COVID vaccine maker AstraZeneca has said booster jabs may not be needed for everyone in the UK.
Sky News - Published

Blood clot risk much higher from COVID than from the vaccine, study finds

A coronavirus infection presents a much higher risk of developing a blood clot than a first dose of either the AstraZeneca or the Pfizer jab, a study has found.
Sky News - Published

Radio host Lisa Shaw died due to rare complications of COVID vaccine, coroner rules

radio host lisa shaw died due to rare complications of covid vaccine, coroner rules
Award-winning radio presenter Lisa Shaw died due to rare complications from the AstraZeneca COVID-19 vaccine, a coroner has ruled.
Sky News - Published

Protection from COVID-19 jabs wanes within six months, study suggests

COVID-19 protection from two doses of the Pfizer or AstraZeneca vaccines begins to wane within six months, new research suggests.  
Sky News - Published

AstraZeneca's CEO is the highest paid executive in Britain

astrazeneca's ceo is the highest paid executive in britain
AstraZeneca's CEO was the highest paid executive in Britain in 2020, earning £15.45 million for his part in delivering a coronavirus vaccine that has been administered tens of millions of times..
Sky News - Published

New medical guidance will help identify and treat rare blood clots linked to AstraZeneca jab

UK scientists have identified markers associated with rare blood clots linked with the Oxford/AstraZeneca COVID-19 vaccine - and have issued guidance to doctors to help treat it effectively and..
Sky News - Published

UK to give Kenya more than 800,000 doses of Oxford-AstraZeneca coronavirus vaccine

The UK will give Kenya 817,000 doses of the Oxford-AstraZeneca coronavirus vaccine, the government has announced.
Sky News - Published

Lancet: Pfizer, AstraZeneca antibody levels start waning after six weeks


IndiaTimes - Published

Why the risk-benefit balance of AstraZeneca jab for young people has shifted

why the risk-benefit balance of astrazeneca jab for young people has shifted
The risks posed by the Oxford-AstraZeneca vaccine to young adults in their 20s and 30s may now be outweighed by its benefits, according to the calculus used by the Joint Committee on Vaccination and..
Sky News - Published

France accepts travellers vaccinated with India's manufactured Covishield - Check full list of countries

The European Union only recognises AstraZeneca manufactured vaccines as a certificate for COVID-19 travel
DNA - Published

France allows visitors with Indian-made AstraZeneca vaccine


IndiaTimes - Published

‘Sputnik, AstraZeneca mix & match results by end of July’


IndiaTimes - Published

Covid-19: Wrong injection technique could also be leading to clots

A new study shows that wrong injection technique could be one of the reasons behind clotting following inoculation by adeno virus-based Covid vaccines, which include AstraZeneca, J&J and Sputnik jabs...
IndiaTimes - Published

Switzerland, Iceland, 7 EU nations approve Covishield for travel entry

Switzerland, Iceland and seven EU countries have approved Covishield, the AstraZeneca vaccine manufactured by Serum Institute of India, a day after India threatened to put European visitors under..
IndiaTimes - Published

Two AstraZeneca jabs give 94% protection against death for over-65s, says PHE

two astrazeneca jabs give 94% protection against death for over-65s, says phe
Two doses of the AstraZeneca vaccine give an estimated 94% protection against dying with coronavirus in over-65s and 92% for those aged 40 to 64, according to Public Health England (PHE).
Sky News - Published

Covishield becomes collateral damage in inter-EU tussle over Chinese vaccines

EMA has listed 4 vaccines, which are Comirnaty (Pfizer), Janssen, Spikevax (previously COVID-19 Vaccine Moderna), and AstraZeneca's Vaxzevria.
DNA - Published

Covishield not a ‘green pass’, Europe-bound Indians fret

BENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of..
IndiaTimes - Published

'Mixing and matching' Oxford and Pfizer jabs could provide greater COVID protection, study suggests

'mixing and matching' oxford and pfizer jabs could provide greater covid protection, study suggests
People who have been double-dosed with the Oxford/AstraZeneca vaccine could have a stronger immune response if they were given a different jab as a booster, a leading scientist has said.
Sky News - Published

No need for booster AZ jab at the moment - despite evidence it restores peak immunity

no need for booster az jab at the moment - despite evidence it restores peak immunity
There is no evidence a third Oxford/AstraZeneca jab is needed at the moment - despite new research suggesting it restores peak immunity, says one of the vaccine's developers.
Sky News - Published

Italian PM receives Pfizer Covid-19 vaccine as 2nd dose after AstraZeneca


IndiaTimes - Published

Vietnam to receive 1 million doses of AstraZeneca vaccine weekly from July


IndiaTimes - Published

AstraZeneca top expert backs India on widening Covishield dose gap


IndiaTimes - Published

When should you take second dose of Covishield vaccine? AstraZeneca says THIS

AstraZeneca on Friday backed the idea of keeping a 12-16 weeks gap between the two doses of the Covishield vaccine.
DNA - Published

AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap


IndiaTimes - Published

AstraZeneca and EU both claim win as court rules on vaccine supply row

astrazeneca and eu both claim win as court rules on vaccine supply row
AstraZeneca and the EU have both claimed victory in a court ruling over the supply of COVID-19 vaccines.
Sky News - Published

Covishield produces more antibodies than Covaxin, finds study

Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..
IndiaTimes - Published

US to ease Covid vaccine input supply: Kamala Harris to PM Modi

US Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..
IndiaTimes - Published

Boris Johnson receives second dose of AstraZeneca COVID vaccine

Boris Johnson has had his second dose of the AstraZeneca COVID vaccine.
Sky News - Published

UK government negotiating with AstraZeneca to secure South African variant vaccine

uk government negotiating with astrazeneca to secure south african variant vaccine
The UK government has begun negotiations with AstraZeneca to secure a "variant vaccine" that can tackle the South African variant, Health Secretary Matt Hancock has said.
Sky News - Published

US redirects vaccine manufacturing supplies allowing India to make additional 20 million Covid vaccine doses

The US government on Friday redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca Covid-19 vaccines.
IndiaTimes - Published

ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin


IndiaTimes - Published

Small number of people suffer stroke after AstraZeneca jab - as experts urge doctors to be alert

small number of people suffer stroke after astrazeneca jab - as experts urge doctors to be alert
Doctors have been told to look out for signs of stroke in patients who received the Oxford/AstraZeneca coronavirus jab after one person died and two others needed hospital treatment.
Sky News - Published

Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study

Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India, a new UK..
IndiaTimes - Published

'It would be a disaster': Vaccine hesitancy in some African nations risks jabs going out of date

'it would be a disaster': vaccine hesitancy in some african nations risks jabs going out of date
When the world-wide vaccine alliance, GAVI, announced that 132,000 AstraZeneca vaccines had been designated for South Sudan, doctors and health officials in this impoverished country were both..
Sky News - Published

3-month gap between doses improves immune response: AZ vax co-developer

A three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and..
IndiaTimes - Published

'Morally wrong' to offer COVID jabs to children while poorer nations suffer, says Oxford expert

'morally wrong' to offer covid jabs to children while poorer nations suffer, says oxford expert
It is "morally wrong" to offer coronavirus jabs to children in wealthy countries when people at greater risk in poorer nations remain unvaccinated, one of the scientists behind the Oxford-AstraZeneca..
Sky News - Published

Biggest AstraZeneca jab maker unlikely to resume exports 'for at least three months'

biggest astrazeneca jab maker unlikely to resume exports 'for at least three months'
The world's biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India's coronavirus crisis.
Sky News - Published

26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt


IndiaTimes - Published

Under-40s to be offered alternative to Oxford jab over blood clot fears

All under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine as a precaution.
Sky News - Published

US 'doing a lot for India' to meet Covid crisis: Joe Biden

President Joe Biden has said that the US was "doing a lot for India" by sending it oxygen and materials to make anti-Covid-19 vaccines. Biden's spokesperson Jen Psaki said that the US government was..
IndiaTimes - Published

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India via the UN-backed COVAX, an initiative devised to give countries access to coronavirus vaccines regardless of their wealth.
IndiaTimes - Published

Serum Institute plans to start Covid vaccine production outside India: Report

The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..
IndiaTimes - Published

5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh Varma

New Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1. Sputnik V is the third vaccine India has..
DNA - Published

India's COVID crisis: US to redirect 20M doses of AstraZeneca vaccines, send raw material to make 5,00,000 doses

Over the weekend, the US announced that it will be diverting raw material to India for manufacturing of COVID-19 vaccines in the country.
DNA - Published

US to share up to 60 million doses of AstraZeneca vaccine with the world

us to share up to 60 million doses of astrazeneca vaccine with the world
The US will share up to 60 million doses of the AstraZeneca vaccine with the world, the White House has said.
Sky News - Published

EU Commission sues AstraZeneca over vaccine contract

eu commission sues astrazeneca over vaccine contract
The European Commission has launched legal action against AstraZeneca for not respecting a contract for the supply of COVID-19 vaccines.
Sky News - Published

 Page 1  〉